US 11,998,425 B2
Fiber materials with improved properties for use in wound treatment
Erik Carlsson, Särö (SE)
Assigned to Mölnlycke Health Care AB, Göburg (SE)
Filed by MÖLNLYCKE HEALTH CARE AB, Gothenburg (SE)
Filed on Dec. 27, 2022, as Appl. No. 18/146,501.
Application 18/146,501 is a continuation of application No. 16/480,049, granted, now 11,559,440, previously published as PCT/EP2018/051064, filed on Jan. 17, 2018.
Claims priority of application No. 17153138 (EP), filed on Jan. 25, 2017.
Prior Publication US 2023/0136758 A1, May 4, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 13/00 (2006.01); A61F 13/0203 (2024.01); A61F 13/0206 (2024.01); A61L 15/24 (2006.01); A61L 15/26 (2006.01); A61L 15/28 (2006.01); A61L 15/46 (2006.01); A61L 15/60 (2006.01); D04H 1/4258 (2012.01); D04H 1/4309 (2012.01)
CPC A61F 13/0209 (2013.01) [A61F 13/0213 (2013.01); A61L 15/24 (2013.01); A61L 15/26 (2013.01); A61L 15/28 (2013.01); A61L 15/46 (2013.01); A61L 15/60 (2013.01); D04H 1/4258 (2013.01); D04H 1/4309 (2013.01); A61L 2300/404 (2013.01)] 15 Claims
OG exemplary drawing
 
1. A fiber material comprising:
a substrate of non-ionic, non-woven fibers, and
at least one additional component, which is an agent that comprises at least one group capable of forming a hydrogen bond,
wherein the non-ionic, non-woven fibers are crosslinked by the agent.
 
11. The fiber material according to claim 1, wherein the amount of agent in the fiber material, relative to the overall weight of the fiber material, is from 15% w/w to 25% w/w.